Uses:
- Advanced breast cancer
- Advanced renal cell carcinoma
- Advanced pancreatic neuroendocrine tumours
- Treatment of subependymal giant cell astrocytoma
Therapeutic Effects:
- Inhibits the activity of mammalian target of rapamycin (mTOR), which regulates cell growth
- Slows the growth of abnormal cancer cells by blocking the mTOR protein
- Reduces the size of tumours and improves outcomes in patients
Interaction with Other Drugs:
- Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products
- Certain medications may interact with Evercon 0.5 mg tablets and reduce effectiveness by causing undesirable side effects
Safety Advices:
- Pregnancy: not recommended; consult your doctor if you are pregnant or planning for pregnancy during the treatment
- Breastfeeding: consult your doctor before breastfeeding
- Lungs: consult your doctor if you have any lung diseases before starting the treatment
- Liver: inform your doctor if you have any liver problems before taking Evercon 0.5 mg tablet
- Alcohol: consuming alcohol may affect the effectiveness of Evercon 0.5 mg tablets; stop consuming alcohol if you are taking this medicine
- Driving: it is unsafe to drive vehicles or operate heavy machinery after taking Evercon 0.5 mg tablets, it may cause dizziness and impair your concentration
Storage:
- Store Evercon 0.5 mg tablet in the original package at room temperature (20°C to 25°C)
- Do not freeze
- Keep it out of reach from children
How to Consume:
- Always take this medicine as prescribed by your doctor
- Take the tablet at the same time every day, with or without food
- Do not break, chew, crush, or break the tablet; swallow the whole tablet with water
- If you forgot to take the tablet, simply take your next dose at the scheduled time; do not take a double dose to make up for a forgotten dose
Side Effects:
- Serious: difficulty breathing or swallowing, swelling of face, lips, tongue, throat, severe itching, red rash, raised bumps
- Common: infection (chills, increased temperature), coughing, wheezing, excessive thirst, high urine output or severely decreased urine output, tiredness, bleeding, increased appetite with weight loss
FAQs:
What should you know before taking Evercon 0.5 mg tablet? Before taking Evercon 0.5 mg tablets, it is important to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, everolimus increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of skin, joint pain or swelling during this treatment.
Is it safe to use Evercon 0.5 mg tablets during pregnancy? Evercon 0.5 mg tablets have the tendency to cause harm to unborn fetus. Inform your healthcare provider before starting this treatment if you are pregnant or have a partner who can become pregnant. Your healthcare provider will conduct a pregnancy test before you start treatment with this drug.
What are the side effects of Evercon 0.5 mg tablet? The common side effects that are likely to occur while you are on the treatment with Evercon 0.5 mg tablets are fever, chills, skin rash, joint pain, swelling, tiredness, loss of appetite, high risk of infection, mouth ulcers, difficulty breathing.
Is it safe to undergo surgery while on treatment with Evercon 0.5 mg tablet? Evercon 0.5 mg tablets may lead to poor wound healing ability. Therefore, it is advisable to tell your physician if you plan to have any surgery before starting or during treatment. Consult your healthcare provider and stop taking tablets at least one week before planned surgery.
Can I drink alcohol while taking Evercon 0.5 mg tablet? It is generally recommended to avoid drinking alcohol while taking Evercon 0.5 mg tablets, as alcohol can increase the risk of liver damage.
Fact Box:
- Molecule name: Everolimus
- Therapeutic class: Antineoplastics
- Pharmacological class: mTOR inhibitors
- Indications:
- Advanced breast cancer
- Advanced renal cell carcinoma
- Advanced pancreatic neuroendocrine tumours
- Treatment of subependymal giant cell astrocytoma